Study of PBK-M2502 for people having digestive exams
Part of Digestive system clinical trials.
This study tests a new medicine called PBK-M2502 to see if it is safe and works well in people who are scheduled for a stomach and colon exam. It may help make the procedure easier or reduce risks, and your participation could help improve care for others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for both an upper endoscopy (stomach exam) and a colonoscopy (colon exam).
- Your body mass index (BMI) must be between 19 and 30.
- You must be willing to give written consent to join.
- You cannot be pregnant or breastfeeding, and if you are a woman of childbearing age, you must be willing to use birth control.
- You must not have uncontrolled high blood pressure or diabetes.
- You must not have had surgery on your colon or abdomen in the last 6 months, unless it's an emergency surgery.
- You must not have HIV, chronic hepatitis B or C, or severe nausea or vomiting that makes it hard to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new medicine, PBK_M2301, moves through the body in healthy adults. It aims to find out how the drug is absorbed and eliminated to guide future studies.
This study tests a new oral liquid called MSP01-T that helps clean out the bowel before a colonoscopy. It is designed for people having a routine screening colonoscopy, and the goal is to see if it works well and is safe.
This study tests a sodium phosphate powder for cleaning the bowel before a colonoscopy. It looks at how safe and effective it is for people in this age group.
This study tests if watching a short video and reading a booklet helps patients prepare better for a colonoscopy compared to just getting standard instructions. Good preparation makes the procedure safer and more effective.
This trial tests MBK-01, capsules made from healthy gut bacteria, to see if they can help people who keep getting diverticulitis. If you've had three or more bouts in the last three years, this study might offer a new treatment option.
This study is evaluating PreveCol, a new second-line stool test for people aged 50–69 who had a positive FIT/FOBT result and are already scheduled for a colonoscopy. It aims to find out if this test can help detect colorectal cancer earlier.
Hear when a new Intestinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.